Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis

PURPOSE: Prostate cancer patients with surprisingly high prostate-specific antigen (PSA) are encountered clinically. However, descriptions of this group of patients are extremely rare in the published literature. This study reports treatment outcome and long-term prognosis for this group of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Hung-Cheng, Hou, Chen-Pang, Lin, Yu-Hsiang, Tsui, Ke-Hung, Chang, Phei-Lang, Chen, Chien-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476709/
https://www.ncbi.nlm.nih.gov/pubmed/28652776
http://dx.doi.org/10.2147/OTT.S134411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476709/
https://www.ncbi.nlm.nih.gov/pubmed/28652776
http://dx.doi.org/10.2147/OTT.S134411

Ejemplares similares